{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T18:53:10Z","timestamp":1777143190943,"version":"3.51.4"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OTT"],"DOI":"10.2147\/ott.s187306","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T18:37:26Z","timestamp":1544121446000},"page":"8823-8833","source":"Crossref","is-referenced-by-count":6,"title":["Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells"],"prefix":"10.2147","volume":"Volume 11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4896-4111","authenticated-orcid":true,"given":"Enrique","family":"P\u00e9rez-C\u00e1rdenas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9592-8527","authenticated-orcid":true,"given":"Luc\u00eda","family":"Taja-Chayeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalina","family":"Trejo-Becerril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Chanona-Vilchis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4201-5935","authenticated-orcid":true,"given":"Alma","family":"Ch\u00e1vez-Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Dom\u00ednguez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6180-8036","authenticated-orcid":true,"given":"Elizabeth","family":"Langley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1220-5014","authenticated-orcid":true,"given":"Alejandro","family":"Garc\u00eda-Carranc\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Due\u00f1as-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,12]]},"container-title":["OncoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=46818","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=46818","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T18:37:26Z","timestamp":1544121446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/antimetastatic-effect-of-epigenetic-drugs-hydralazine-and-valproic-aci-peer-reviewed-article-OTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ott.s187306","relation":{},"ISSN":["1178-6930"],"issn-type":[{"value":"1178-6930","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}